EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 205 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $977,000 | -25.7% | 31,494 | -1.7% | 0.04% | -13.3% |
Q1 2022 | $1,315,000 | +223.1% | 32,029 | +242.8% | 0.04% | +246.2% |
Q4 2021 | $407,000 | -20.4% | 9,342 | -8.4% | 0.01% | -27.8% |
Q3 2021 | $511,000 | -65.4% | 10,200 | -56.5% | 0.02% | -61.7% |
Q2 2021 | $1,478,000 | -49.6% | 23,452 | -25.7% | 0.05% | -53.0% |
Q1 2021 | $2,933,000 | +52.4% | 31,569 | +47.0% | 0.10% | +56.2% |
Q4 2020 | $1,924,000 | +51.1% | 21,476 | +74.3% | 0.06% | +36.2% |
Q3 2020 | $1,273,000 | +30.4% | 12,321 | -0.2% | 0.05% | +27.0% |
Q2 2020 | $976,000 | +43.7% | 12,345 | -48.8% | 0.04% | +32.1% |
Q2 2016 | $679,000 | -22.1% | 24,130 | +0.5% | 0.03% | -24.3% |
Q1 2016 | $872,000 | -9.2% | 24,000 | 0.0% | 0.04% | -7.5% |
Q4 2015 | $960,000 | +46.6% | 24,000 | +4.3% | 0.04% | +48.1% |
Q3 2015 | $655,000 | – | 23,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 306,838 | $2,255,000 | 0.50% |
BOULDER HILL CAPITAL MANAGEMENT LP | 23,000 | $169,050 | 0.32% |
EMC Capital Management | 2,147 | $397 | 0.31% |
Values First Advisors, Inc. | 50,903 | $374,135 | 0.23% |
AIMZ Investment Advisors, LLC | 52,122 | $383,097 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 839,433 | $6,169,833 | 0.15% |
PALISADE CAPITAL MANAGEMENT, LP | 538,418 | $3,957,372 | 0.10% |
AXQ CAPITAL, LP | 10,100 | $74,235 | 0.09% |
SummerHaven Investment Management, LLC | 15,285 | $112,345 | 0.07% |
CAXTON ASSOCIATES LP | 50,265 | $369,448 | 0.06% |